Navigation Links
VIVUS Reports First Quarter 2011 Financial Results
Date:5/2/2011

in the offspring of women who were exposed to topiramate during pregnancy. We have reached agreement, subject to the finalization of the written protocol, with the FDA on the retrospective observational study objectives and design, primary endpoints, and eligibility criteria. The co-primary endpoints will be the relative risk of major congenital malformations and oral cleft in the offspring of women exposed to topiramate during pregnancy as compared to a control group that was not exposed to topiramate. The retrospective observational study, will be called FORTRESS, for Fetal Outcome Retrospective TopiRamate ExpoSure Study. In addition, we discussed with the FDA a potential resubmission of the QNEXA NDA for a limited indication, which would include only men and women of non-child bearing potential. Agreement on the content of such a submission has also been reached, should we choose to pursue a limited indication. The final indication and timing of the resubmission will be dependent upon the results of the retrospective observational study. Our goal is to resubmit the QNEXA NDA in the fourth quarter of 2011. We have confirmed with the FDA that any resubmission will be considered a Class 2 resubmission with a 6-month review goal. The FDA has also indicated that a resubmission would likely be discussed at a second advisory committee meeting.  

About VIVUS VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health. The company's lead investigational product in clinical development, QNEXA, has completed phase 3 clinical trials for the treatment of obesity and is currently being considered for approval by US and EU regulators. VIVUS received a Complete Response Letter, or CRL, to the initial QNEXA NDA on October 28, 2010. QNEXA is also in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea. In the area of sexual health, VIVUS is in phase 3 development
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. VIVUS to Present at Four Upcoming Investor Conferences in May
2. VIVUS to Present at the 10th Annual Needham Healthcare Conference
3. Data on VIVUS QNEXA to be Presented in Six Posters at The Obesity Societys Annual Meeting
4. VIVUS to Present at Four Upcoming Investor Conferences
5. VIVUS to Present at Two Upcoming Investor Conferences
6. VIVUS Reports Third Quarter 2009 Highlights and Financial Results
7. VIVUS Announces Positive Results From Two Phase 3 Studies; Obese Patients on Qnexa Achieve Average Weight Loss up to 14.7% and Significant Improvements in Co-Morbidities
8. VIVUS to Present at Four Upcoming Healthcare Conferences
9. VIVUS to Present at the Canaccord Adams 29th Annual Global Growth Conference
10. VIVUS to Present at the Needham and Company Life Sciences Conference
11. Data on VIVUS Qnexa To Be Presented During Two Podium Presentations at ADA Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... Waterloo, ON (PRWEB) August 01, 2014 ... researchers has led to a better understanding embryonic ... differentiate and reorganize into structurally and functionally distinct ... devastating physical defects. Prof. Todd McDevitt, Melissa ... that biophysical signals interact with biochemical cues to ...
(Date:7/31/2014)... July 31, 2014 Food and ... increasingly searching for food alternatives that offer variety, ... The food ingredient market has numerous players operating ... as Vital Force Technology (VFT). VFT is ... 4,000 energetic patterns, all tested to produce stable, ...
(Date:7/31/2014)... Dallas, Texas (PRWEB) August 01, 2014 ... Global and China Polyurethane Resin Industry” is ... Polyurethane Resin market. The report introduces Polyurethane ... application, and industry chain structure and industry ... analysis, including China’s domestic market as well ...
(Date:7/31/2014)... -- Today BioSpace , the leading life sciences employment and news ... life sciences community in Illinois , Indiana ... Michigan , Minnesota , ... and Wisconsin . BioMidwest is a ... postings on BioSpace originating in this region in 2013. The life sciences ...
Breaking Biology Technology:Study Links Biomechanics and Gene Expression in Stem Cells 2Functional Ingredient Manufacturer – Vital Force Technology Infuses Raw Materials & Ingredients with Subtle Energy Formula 2Polyurethane Resin Industry & Thermoplastic Polyurethane Market (China, Global) Analysis Now at DeepResearchReports.com 2Polyurethane Resin Industry & Thermoplastic Polyurethane Market (China, Global) Analysis Now at DeepResearchReports.com 3Polyurethane Resin Industry & Thermoplastic Polyurethane Market (China, Global) Analysis Now at DeepResearchReports.com 4Midwest Biotech Leaders Featured On BioSpace Map 2
... of voltage, resistance and current with highest accuracy ... prerequisites are extremely pure semiconductor layers where high-mobile ... residual impurities. To be prepared for future developments ... new molecular beam epitaxy system optimized for the ...
... FRANCISCO, Calif., Aug. 29 Anesiva,Inc. (Nasdaq: ANSV ... and chief executive officer, will present at BioCentury,s,Newsmakers in ... September,4, 2008 at 2:00 p.m. ET., To access ... on,to http://www.anesiva.com, go to the Investors page, ...
... Pharmos Corporation,(Nasdaq: PARS ) today announced that ... Rehovot, Israel, and manage those activities currently,based in ... Iselin, New,Jersey., The research programs in Israel ... preclinical development of PRS-639,058 for,neuropathic pain. Additionally the ...
Cached Biology Technology:'Racetrack' for fast electrons in semiconductor structures 2Anesiva to Present at BioCentury Newsmakers Conference on September 4, 2008 2Pharmos Corporation Announces That it Will Cease Operations in Israel 2
(Date:8/1/2014)... a new study, including two Simon Fraser University ... representatives and policymakers must collaborate closely on minimizing ... development. Viorel Popescu and Maureen Ryan, David H. ... department, are among eight international co-authors of the ... and the Environment . , Shale gas development ...
(Date:7/31/2014)... shale rock has increased by more than 700 ... fully understand the industry,s effects on nature and ... Frontiers in Ecology and the Environment . ... scientific examination, a team of eight conservation biologists ... concluded that determining the environmental impact of gas-drilling ...
(Date:7/31/2014)... was found to be a key gene responsible for hearing ... hair cells of the inner ear that contracts and expands ... antique phonograph horn, amplify sound waves to make hearing more ... the advanced online edition of Molecular Biology and Evolution ... also independently evolved to play a critical role in the ...
Breaking Biology News(10 mins):Scientists warn time to stop drilling in the dark 2Scientists warn time to stop drilling in the dark 3'Fracking' in the dark: Biological fallout of shale-gas production still largely unknown 2'Fracking' in the dark: Biological fallout of shale-gas production still largely unknown 3
... Tenn., March 12, 2008 -- Noted green energy entrepreneur ... years Global Venture Challenge, a business competition and venture ... National Laboratory. The focus of this years event ... energy efficiency and power generation sectors. Sridhar, CEO ...
... that could destroy most of the worlds main wheat crops ... than research had suggested, leaving millions to starve. The fungus, ... already be in Pakistan. If so, this is extremely bad ... crop, it is also the gateway to the Asian breadbasket, ...
... Coring in Antarctica), one of the European Science Foundations ... one of this years winners of the Descartes Prize ... to three European teams for outstanding transnational projects in ... 12 March in Brussels. The EPICA project - carried ...
Cached Biology News:Killer fungus spells disaster for wheat 2Killer fungus spells disaster for wheat 3ESF's European ice core project EPICA receives prestigious Descartes Prize 2ESF's European ice core project EPICA receives prestigious Descartes Prize 3
... Convenient, easy-to-use kits for arraying ... detection using common lab equipment. DiscoverLight ... analysis of your protein, cell lysate ... format. The kits include specially designed ...
... facilitate the hybridization of DNA or Protein ... x 75mm glass slides. The proprietary design ... for poor flatness, as is often the ... volume chamber (67uL analytical cavity volume) eliminates ...
MAb to Myoglobin Cardiac...
... The SDSaway reagent is a valuable tool ... The presence of SDS in biological ... tightly bound SDS-protein complex, inhibits enzymatic activity ... presents as a contaminant in mass spectrometry ...
Biology Products: